Coronavirus
Structural Task Force

Recent Posts

December 24, 2020
SARS-CoV-2 Entry Animation from Iwasa Group – a little Christmas Present to the Scientific Community

See how the virus binds to a host cell and manages to insert its RNA on a molecular level! Merry Christmas from the Iwasa Lab and the Coronavirus Structural Task Force!

Read More
December 23, 2020
The new mutation of SARS-CoV-2

The new strain of Coronavirus - what do we know?

Read More
December 22, 2020
How do we know that Viruses exist?

If you want to know how exactly science found out about the existence of viruses, this post is for you!

Read More
December 10, 2020
How reliable is the Pfizer-BioNTech claim that their vaccine is 90 percent effective?

On Nov 9th, 2020 Pfizer issued a press release stating their conclusion that the COVID-19 vaccine they developed with BioNTech appeared to be 90% effective. While their test contained over 43,000 volunteers they had only detected 94 cases of COVID-19. How confident can you be with only 94 cases? I decided to explore this matter […]

Read More
December 7, 2020
VIP treatment: Very Important Proteins

Methyltransferases manage to fool the host cell into giving viral RNA VIP treatment. For details, read this blog post by Cameron Fyfe and Lea von Soosten!

Read More
November 9, 2020
What does the Pfizer press release really mean?

A press release came out today from Pfizer and Binotech with a very exciting announcement, but what does it say? Andrea shares her insights.

Read More
November 9, 2020
The healing power of crystals

Join us at Wednesday the 11th for this not quite serious talk about some real science behind modern therapies!

Read More
October 30, 2020
Accessory Protein 7a: Key Role in Pathogenesis?

The genome of the novel SARS-CoV-2 codes for an ORF1a/ ORF1ab (open reading frame) polyprotein containing sixteen non-structural proteins (NSP) and four structural proteins. The genome also has multiple ORFs coding for accessory proteins through a frame shift. These accessory proteins are not necessary for viral replication but might play a key role in pathogenesis […]

Read More
September 1, 2020
Exoribonuclease: Making the most when mistakes are made

Exoribonuclease is a domain of nsp14 responsible for chopping out nucleotides incorrectly added by RdRp. This enzyme allows the large 29.9 kb genome of SARS-CoV-2 and remains a worthwhile target for drugs to fight this virus.

Read More
August 20, 2020
Rage Against the Machine with Remdesivir

RNA Polymerase is central to virus replication, and Remdesivir stops it. How? Learn here!

Read More
Coronavirus Structural Taskforce
Top